Helixmith Co Ltd (084990)

Currency in KRW
4,160
+130(+3.23%)
Closed·
084990 Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
084990 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
3,9554,265
52 wk Range
2,1154,950
Key Statistics
Bid/Ask
4,150.00 / 4,160.00
Prev. Close
4,030
Open
4,030
Day's Range
3,955-4,265
52 wk Range
2,115-4,950
Volume
181.84K
Average Volume (3m)
256.9K
1-Year Change
-3.37%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
084990 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Net income is expected to grow this year

Helixmith Co Ltd News & Analysis

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy

Helixmith Co Ltd Company Profile

Helixmith Co., Ltd develops biologic and natural nutraceutical products. The company offers LAYLA Tab for osteoarthritis; Allex and Allex i for hypersensitivity improvement; and Mnemosyne for memory improvement. Its lead gene therapy product is Engensis (VM202), which is in a phase III clinical trial for diabetic peripheral neuropathy and diabetic foot ulcer; a phase II clinical trial for amyotrophic lateral sclerosis (ALS) and claudication; and a phase I clinical trial for charcot-marie-tooth disease and coronary artery disease. The company also develops VM507, an antibody that can detect and activate c-MET for chronic kidney disease; NM101 for peripheral neuropathy; NM301 for ALS; NM302; HX204 for inflammatory bowel disease; HX109 for prostate health; HX110 for respiratory health; and HX112 for climacteric women’s health. The company was formerly known as ViroMed Co., Ltd. and changed its name to Helixmith Co., Ltd in April 2019. Helixmith Co., Ltd was founded in 1996 and is based in Seoul, South Korea.

Compare 084990 to Peers and Sector

Metrics to compare
084990
Peers
Sector
Relationship
P/E Ratio
−16.7x−4.4x−0.5x
PEG Ratio
−0.20−0.070.00
Price/Book
1.4x2.7x2.6x
Price / LTM Sales
38.2x5.6x3.3x
Upside (Analyst Target)
-0.0%40.6%
Fair Value Upside
Unlock8.9%5.3%Unlock

Earnings

Latest Release
May 19, 2025
EPS / Forecast
-33.00 / --
Revenue / Forecast
930.47M / --
EPS Revisions
Last 90 days

084990 Income Statement

People Also Watch

175,000
068270
-0.57%
684,000
214450
+2.86%
134,500
267250
+0.67%
103,700
000270
+0.48%
139.23
CRCL
-9.10%

FAQ

What Stock Exchange Does Helixmith Trade On?

Helixmith is listed and trades on the KOSDAQ stock exchange.

What Is the Stock Symbol for Helixmith?

The stock symbol for Helixmith is "084990."

What Is the Helixmith Market Cap?

As of today, Helixmith market cap is 191.56B.

What Is Helixmith's Earnings Per Share (TTM)?

The Helixmith EPS (TTM) is -251.71.

When Is the Next Helixmith Earnings Date?

Helixmith will release its next earnings report on 11 Nov 2025.

From a Technical Analysis Perspective, Is 084990 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Helixmith Stock Split?

Helixmith has split 6 times.

How Many Employees Does Helixmith Have?

Helixmith has 33 employees.

What is the current trading status of Helixmith (084990)?

As of 15 Aug 2025, Helixmith (084990) is trading at a price of 4,160.00, with a previous close of 4,030.00. The stock has fluctuated within a day range of 3,955.00 to 4,265.00, while its 52-week range spans from 2,115.00 to 4,950.00.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.